6533b858fe1ef96bd12b59ab

RESEARCH PRODUCT

Doxorubicin plus dacarbazine (DTIC) in advanced solitary fibrous tumor (SFT): An Italian retrospective case series analysis.

Salvatore ProvenzanoSilvana PilottiGiuseppe BadalamentiVittoria ColiaCarlo MorosiGianpaolo DagradaBruno VincenziAngelo Paolo Dei TosSilvia StacchiottiRossella BertulliPaolo G. CasaliMaristella SaponaraMichela Libertini

subject

OncologyCancer Researchmedicine.medical_specialtyChemotherapySolitary fibrous tumorSeries (stratigraphy)Anthracyclinebusiness.industrymedicine.medical_treatmentfungifood and beverages.medicine.diseaseOncologyInternal medicineMedicineDoxorubicinDacarbazine - DTICbusinessTrabectedinmedicine.drug

description

11042Background: The reported response rate to chemotherapy (CT) in SFT is low both with anthracycline-based regimens ( ≤ 20%) and with trabectedin ( < 10%). DTIC can be active. We report on the co...

https://doi.org/10.1200/jco.2016.34.15_suppl.11042